Drugs / 5LGr
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01501695 | Jan 2008 → Nov 2010 | Tourette syndrome, chronic tic disorder | Tasly Pharmaceuticals, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 5-LGr | “The purpose of this study was to formally evaluate the efficacy and safety of 5-Ling Granule (5-LGr), a proprietary polyherbal product, for the treatment of patients with TS in...” PMID 26072932 ↗ Jun 2015 |
| Known as | 5-Ling Granule | “The purpose of this study was to formally evaluate the efficacy and safety of 5-Ling Granule (5-LGr), a proprietary polyherbal product, for the treatment of patients with TS in...” PMID 26072932 ↗ Jun 2015 |
| Modality | Traditional medicine (herbal / TCM) | “5LGr is a kind of traditional Chinese medicine(TCM)” NCT01501695 ↗ |